首页> 美国卫生研究院文献>IUCrJ >Structural studies of P-type ATPase–ligand complexes using an X-ray free-electron laser
【2h】

Structural studies of P-type ATPase–ligand complexes using an X-ray free-electron laser

机译:使用X射线自由电子激光的P型ATPase-配体配合物的结构研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Membrane proteins are key players in biological systems, mediating signalling events and the specific transport of e.g. ions and metabolites. Consequently, membrane proteins are targeted by a large number of currently approved drugs. Understanding their functions and molecular mechanisms is greatly dependent on structural information, not least on complexes with functionally or medically important ligands. Structure determination, however, is hampered by the difficulty of obtaining well diffracting, macroscopic crystals. Here, the feasibility of X-ray free-electron-laser-based serial femtosecond crystallography (SFX) for the structure determination of membrane protein–ligand complexes using microcrystals of various native-source and recombinant P-type ATPase complexes is demonstrated. The data reveal the binding sites of a variety of ligands, including lipids and inhibitors such as the hallmark P-type ATPase inhibitor orthovanadate. By analyzing the resolution dependence of ligand densities and overall model qualities, SFX data quality metrics as well as suitable refinement procedures are discussed. Even at relatively low resolution and multiplicity, the identification of ligands can be demonstrated. This makes SFX a useful tool for ligand screening and thus for unravelling the molecular mechanisms of biologically active proteins.
机译:膜蛋白是生物系统中的关键角色,介导信号传递事件和特定的转运,例如:离子和代谢产物。因此,大量目前批准的药物靶向膜蛋白。了解它们的功能和分子机理在很大程度上取决于结构信息,尤其是与具有功能或医学上重要配体的复合物有关。然而,由于难以获得衍射良好的宏观晶体而难以进行结构确定。在此,证明了使用各种天然来源和重组P型ATPase复合物的微晶,基于X射线自由电子激光的系列飞秒晶体学(SFX)用于确定膜蛋白-配体复合物的结构的可行性。数据揭示了各种配体的结合位点,包括脂质和抑制剂,例如标志性的P型ATPase抑制剂原钒酸盐。通过分析配体密度和整体模型质量的分辨率相关性,讨论了SFX数据质量指标以及合适的优化程序。即使在相对较低的分辨率和多样性下,也可以证明配体的鉴定。这使得SFX成为用于配体筛选并由此揭示生物活性蛋白的分子机制的有用工具。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号